The Evolution Of The Cell And Gene Therapy Field

Cell and gene therapies are revolutionizing the field of medicine by enabling treatment for serious or life-threatening diseases with previously unmet medical needs. There is still a long arc of innovations to be made in this burgeoning industry that will both address remaining unmet needs and increase patient access to advanced therapies..

Early preparation for commercialization will be key for sponsors advancing a novel therapeutic toward approval. Ensuring patients have access is a complicated process as regulatory guidelines and payer acceptance can delay timelines. Lung-I Cheng, Vice President, Cell and Gene Therapy, AmerisourceBergen, discusses emerging trends in the CGT market and details the value of leveraging the expertise of knowledgeable partners and stakeholders.